The Medicare GLP-1 Bridge program is designed to provide temporary access to GLP-1 obesity drugs while federal officials examine longer-term approaches to obesity treatment through Medicare.
Federal officials say the practice inflated costs paid by Medicare and the Federal Employees Health Benefits Program. A whistleblower will receive $159,210.
The drugmaker is restricting access to a drug discount program intended for safety-net hospitals in a move the company says is needed to identify waste, fraud and abuse.
India is a marketplace booming with smartphones duking it out on various price points. From the killer-budget phones to the ultra-flagships, there is a phone for everyone. Of course, the market always ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results